As a response modifier of estrogen and progesterone, especially estradiol, melatonin exerts its anti-estrogen effect by interacting with ER-α [103,104,105] and inhibits the BC cell proliferation induced by estradiol [106,107,108]. This evidence concerns the gene ESR1 and breast cancer.